Unlearn.AI provides a groundbreaking product that leverages artificial intelligence to transform clinical trials. Utilizing digital twin technology, Unlearn.AI enables medical researchers to conduct quicker and more accurate clinical trials. By virtually simulating patients, this technology reduces the need for large control groups, enhances trial efficiency, and accelerates the development of personalized medical treatments. This approach not only saves time and resources but also improves the accuracy and reliability of clinical trials.

FlowTrials is a platform designed to connect patients with over 20,000 clinical trials. Patients can search for trials by condition or location, review study details, and manage their participation via a simple dashboard. FlowTrials prioritizes patient safety by thoroughly vetting trial sponsors and ensuring transparent and ethical trial processes. The platform is designed to make clinical research accessible, safe, and beneficial for patients by offering expert care, fair compensation, and flexible scheduling.

Insight is an advanced AI-powered platform specifically designed for medical research. It assists users in conducting efficient literature reviews, formulating hypotheses, designing experiments, and identifying targets. By leveraging peer-reviewed publications, it offers a comprehensive solution for researchers to generate scientific summaries and accelerate their projects. The platform aims to redefine how medical research is conducted, making it faster and more efficient.